Assessment of S-ICD Eligibility With 12-Lead ECG (EL-SID)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03209726 |
Recruitment Status :
Active, not recruiting
First Posted : July 6, 2017
Last Update Posted : September 22, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Implantable Defibrillator User |
Study Type : | Observational |
Actual Enrollment : | 106 participants |
Observational Model: | Cohort |
Time Perspective: | Cross-Sectional |
Official Title: | Assessment of Subcutaneous Implantable Cardioverter Defibrillator Eligibility With 12-lead Electrocardiogram |
Actual Study Start Date : | June 21, 2017 |
Estimated Primary Completion Date : | December 31, 2020 |
Estimated Study Completion Date : | December 31, 2020 |

- Amplitudes of R- and T-waves (and R/T ratios) on a special precordial ECG [ Time Frame: at the day of ECG recording (cross-sectional study) ]Amplitudes of R- and T-waves (and R/T ratios) on a special ECG (recorded for Subcutaneous ICD eligibility assessment)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- medical condition, predisposing patient to life-threatening ventricular arrhythmias, eligible for currently approved ICD indications for primary or secondary prevention of sudden cardiac death
Exclusion Criteria:
- Acute medical condition (e.g. acute myocardial infarction, severe trauma, post-surgery, admitted to ICU)
- End stage organ failure
- Pregnancy
- Patient, legal guardian or authorized representative is unable or unwilling to cooperate or give written informed consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03209726
United States, Oregon | |
Oregon Health and Science University | |
Portland, Oregon, United States, 97239 |
Responsible Party: | Larisa Tereshchenko, Associate Professor of Medicine, Oregon Health and Science University |
ClinicalTrials.gov Identifier: | NCT03209726 |
Other Study ID Numbers: |
STUDY00016034 |
First Posted: | July 6, 2017 Key Record Dates |
Last Update Posted: | September 22, 2020 |
Last Verified: | September 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |